Also the human herpesvirus 8 (also known as HHV-8, Kaposi’s sarcoma-associated herpesvirus, or KSHV) as it is found in nearly all patients with human immunodeficiency virus (HIV) who develop multicentric Castleman’s
“Human Herpes Virus-8 (HHV-8) and Kaposi’s Sarcoma (KS)” Human herpes virus (HHV-8) poses a challenging task for researchers determining its role in Kaposi’s sarcoma (KS). People with KS are distinguished by their placement in four categories. The first category consists of elderly males of Mediterranean or Eastern European Jewish descent. The second category consists of individuals of all ages from Africa. Neither one of these categories is associated with immune deficiency or known environmental
viruses which allows them to persist indefinitely in their host after a primary or secondary infection (3). The mechanisms of establishment and maintenance of latency are not yet fully elucidated, but molecular studies are in progress for several herpesvirus models and recent data suggest that latency is under the control of viral latency genes. New hypotheses are available concerning the coding regions involved in the establishment and maintenance of latency and for the level of genome expression during
The patient’s CD4 T-cell count is below 200 cells/mm3 and the patient is starting to have severe immunodeficiency. Patient begins to have severe opportunistic infections an... ... middle of paper ... ...cers that affect the blood such as Kaposi’s sarcoma. It will be difficult for a HIV/AIDS patient to keep away from all of these different types of infections but constantly taking their antiretroviral medication is the first step. Routine physicals, blood tests, and eye examinations are significant